Login or sign up
For business

益方生物 inventisbio

3.9· 11 reviews
Average ratingAverage
3.9/ 5

Based on 11 reviews

527%
436%
336%
20%
10%
Ask AI

Ask Trustburn about 益方生物 inventisbio

Based on 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Fredric Yerman
Reviews 1

I recently had the pleasure of working with a biotech company and was thoroughly impressed with their professionalism and expertise. They provided top-notch service and delivered exceptional results. I highly recommend their services to anyone in need of biotech solutions.

Luc Boilly
Reviews 1

👍 Inventisbio has been a game-changer for our company. Their innovative solutions have helped us overcome many challenges and achieve outstanding results. We are extremely satisfied with their services and highly recommend them to others in the industry. Keep up the good work! 👍

Aravind Manickam
Reviews 1

I have been a customer of Inventisbio for a while now and I must say, their service is truly exceptional. The team is professional, knowledgeable, and always go above and beyond to meet my needs. The quality of their work is second to none, and I have always been impressed with the results they deliver. I highly recommend Inventisbio to anyone in need of biotech services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About 益方生物 inventisbio

InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.

Categories
Pharmaceuticals